ArticleCell death & disease2021

Establishment of a novel mesenchymal stem cell-based regimen for chronic myeloid leukemia differentiation therapy.

Shiman Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.